Back to search

National and Kapodistrian University of Athens

Επίπεδα λιποκινών σε ασθενείς με χρόνια ηπατίτιδα

Abstract

dc:description

Adipokines are recently discovered adipose tissue hormones with systemic effects. Leptin and adiponectin have been implicated in the pathogenesis and progression of non-alcoholic fatty liver disease and chronic hepatitis C, while little is known about the role of resistin in chronic liver diseases. The potential role of adipokines on patients with chronic hepatitis B is inadequately studied. In the present study, we investigated the above three serum adipokines levels in relation to the etiology of liver disease and determined their associations with various anthropometrical, epidemiological, metabolic host factors as well as with histological severity. We prospectively evaluated 146 patients who consecutively underwent liver biopsy. Of those 146 patients, 52 had HBeAg-negative chronic hepatitis B (CHB), 70 had chronic hepatitis C (CHC) and 24 non-alcoholic steatohepatitis (NASH). Detailed epidemiological, anthropometrical and laboratory data were recorded and insulin resistance was calculated using the HOMA index. All serum adipokines levels were determined in stored serum samples using immunoenzymometric assays. Serum samples were obtained after an overnight fasting on the liver biopsy day and were stored in aliquots at -200C until assayed. Histological lesions were evaluated blindly according to Ishak’s and Brunt’s classification for CHB/CHC and NASH, respectively. Serum adipokine levels were similar between CHB and CHC, while CHB/CHC compared to NASH patients had significantly lower leptin (8.3±7.3 vs. 17.6±16.6 ng/mL, P=0.012) and higher adiponectin (10.2±5.1 vs. 7.5±4 µg/mL, P=0.018) and resistin levels (7.1±2.5 vs. 5.7±2.8 ng/mL, P=0.016). In CHB/CHC, there was no significant association between steatosis or necroinflammation and adipokines levels, while presence of moderate/severe fibrosis (stage 4-6) was associated with higher leptin and adiponectin levels in male but not in female patients. Serum leptin and resistin levels were associated with severe fibrosis in NASH patients; however due to the small sample size this finding could not be verified in multivariate analysis. Lower resistin levels were independently associated with moderate/severe fibrosis in chronic viral hepatitis irrespective of gender or other factors (adjusted odds ratio=0.788, P=0.035). In conclusion, serum adipokines levels depended on the etiology of liver disease and differed between chronic viral hepatitis and NASH, but not between CHB and CHC. In CHB/CHC, resistin levels are independently associated with fibrosis severity, while it seems to be a gender effect in the association of leptin and adiponectin levels with fibrosis.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsochatzis, Emmanouil
  • Τσόχατζης, Εμμανουήλ

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/22971

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsochatzis, Emmanouil; Τσόχατζης, Εμμανουήλ. Επίπεδα λιποκινών σε ασθενείς με χρόνια ηπατίτιδα. National and Kapodistrian University of Athens, 2008. http://hdl.handle.net/10442/hedi/22971